Effectiveness of manual interventions on overall symptoms, pain and quality of life in patients with chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.
메타분석
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
646 patients were included.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSIONS] Low- to very low-certainty evidence suggests that manual interventions may reduce core symptoms and pain associated with CIPN, and potentially improve sleep quality and quality of life. However, due to high heterogeneity and risk of bias, these findings should be interpreted with caution.
[PURPOSE] The systematic review and meta-analysis aim to thoroughly assess the efficacy of manual interventions like massage therapy, reflexology, and acupressure techniques in relation to overall sym
- p-value P < 0.00001
- 연구 설계 systematic review
APA
Chen YX, He WY, et al. (2026). Effectiveness of manual interventions on overall symptoms, pain and quality of life in patients with chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 34(4). https://doi.org/10.1007/s00520-026-10530-3
MLA
Chen YX, et al.. "Effectiveness of manual interventions on overall symptoms, pain and quality of life in patients with chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, vol. 34, no. 4, 2026.
PMID
41792539
Abstract
[PURPOSE] The systematic review and meta-analysis aim to thoroughly assess the efficacy of manual interventions like massage therapy, reflexology, and acupressure techniques in relation to overall symptoms, pain, and quality of life (QOL) in patients suffering from CIPN.
[METHODS] A total of eight Chinese and English databases were searched, including PubMed, Embase, Cochrane Library, Web of Science, CINAHL, ProQuest, China National Knowledge Infrastructure, and Wan Fang Database. The searching lasted from the establishment of each database to July 2025. The study aims to include randomized controlled trials (RCTs) and quasi-experimental studies. The risk of bias was assessed using the Cochrane risk of bias tool. The primary outcome measures were symptoms of CIPN, pain, and QOL. Standard Deviation (SMD) and 95% CI were calculated in a random-effects model. This study was registered on the International Prospective Register of Systematic Reviews (PROSPERO, CRD420251112391).
[RESULTS] In total, 11 RCTs with a total of 646 patients were included. The meta-analysis showed that manual interventions may improve primary outcomes, including quality of life (SMD = 1.05; 95% CI = 0.60, 1.50; P < 0.00001), sensory (SMD = -0.62; 95% CI = -0.88, -0.35; P < 0.00001), and motor (SMD = -0.42; 95% CI = -0.72, -0.12; P = 0.006) symptoms, with low to moderate levels of heterogeneity. Although the aggregated data for overall CIPN symptoms (SMD = -1.67; 95% CI = -3.03, -0.30; P = 0.02) and pain (SMD = -0.77; 95% CI = -1.31, -0.24; P = 0.006) were statistically significant, they showed high heterogeneity (I > 90%), which may be related to the limited number of existing studies and differences in intervention details.
[CONCLUSIONS] Low- to very low-certainty evidence suggests that manual interventions may reduce core symptoms and pain associated with CIPN, and potentially improve sleep quality and quality of life. However, due to high heterogeneity and risk of bias, these findings should be interpreted with caution.
[METHODS] A total of eight Chinese and English databases were searched, including PubMed, Embase, Cochrane Library, Web of Science, CINAHL, ProQuest, China National Knowledge Infrastructure, and Wan Fang Database. The searching lasted from the establishment of each database to July 2025. The study aims to include randomized controlled trials (RCTs) and quasi-experimental studies. The risk of bias was assessed using the Cochrane risk of bias tool. The primary outcome measures were symptoms of CIPN, pain, and QOL. Standard Deviation (SMD) and 95% CI were calculated in a random-effects model. This study was registered on the International Prospective Register of Systematic Reviews (PROSPERO, CRD420251112391).
[RESULTS] In total, 11 RCTs with a total of 646 patients were included. The meta-analysis showed that manual interventions may improve primary outcomes, including quality of life (SMD = 1.05; 95% CI = 0.60, 1.50; P < 0.00001), sensory (SMD = -0.62; 95% CI = -0.88, -0.35; P < 0.00001), and motor (SMD = -0.42; 95% CI = -0.72, -0.12; P = 0.006) symptoms, with low to moderate levels of heterogeneity. Although the aggregated data for overall CIPN symptoms (SMD = -1.67; 95% CI = -3.03, -0.30; P = 0.02) and pain (SMD = -0.77; 95% CI = -1.31, -0.24; P = 0.006) were statistically significant, they showed high heterogeneity (I > 90%), which may be related to the limited number of existing studies and differences in intervention details.
[CONCLUSIONS] Low- to very low-certainty evidence suggests that manual interventions may reduce core symptoms and pain associated with CIPN, and potentially improve sleep quality and quality of life. However, due to high heterogeneity and risk of bias, these findings should be interpreted with caution.
MeSH Terms
Humans; Quality of Life; Peripheral Nervous System Diseases; Randomized Controlled Trials as Topic; Antineoplastic Agents; Massage; Acupressure; Neoplasms; Pain Management
같은 제1저자의 인용 많은 논문 (5)
- "A machine that won't shut down, a clogged pipe": a qualitative study on the lived experience and integrative coping strategies of Chinese cancer patients with insomnia and cognitive impairment.
- Role of microRNA-136 in -induced early-stage gastric cancer: Mechanistic insights and future directions.
- Rapid Microfluidic Drug Sensitivity Testing Within 5 Days Using Minimal Clinical Tumor Samples.
- Final overall survival analysis and exploratory biomarker study from JUPITER-06: a randomized phase III trial of toripalimab plus chemotherapy in advanced esophageal squamous-cell carcinoma.
- Global trend and disparity in the burden of thyroid cancer attributable to high body-mass index from 1990 to 2021 and projection to 2049: a systematic analysis based on the Global Burden of Disease Study 2021.